{"id":"W2480887942","doi":"10.1200/jco.2012.30.4_suppl.604","title":"IXOA regimen, irinotecan (I), capecitabine (X), oxaliplatin (O), and bevacizumab (A), as first-line therapy for advanced unresectable colorectal cancer (aCRC): Preliminary results.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Neutropenia; Regimen; Febrile neutropenia; Irinotecan; Internal medicine; Gastroenterology; Nausea; Oxaliplatin; Bevacizumab; Surgery; Toxicity; Colorectal cancer; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004605339,0.0005082488,0.0004885694,0.0002872219,0.0002085647,0.0003740095,0.000336435,0.0002276905,0.001587103],"category_scores_gemma":[0.0002902779,0.0001874248,0.0003385367,0.0002565259,0.0002768697,0.0002101154,0.0001896751,0.0008712748,0.0003168058],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004188458,"about_ca_system_score_gemma":0.0004797669,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008117421,"about_ca_topic_score_gemma":0.002151219,"domain_scores_codex":[0.9998969,0.0000353861,0.000008518986,0.00001792716,0.00001939311,0.00002194718],"domain_scores_gemma":[0.9998491,0.00003204339,0.0000271192,0.00001172161,0.000007491661,0.00007240592],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1466311,0.04483446,0.03165575,0.001798951,0.001220951,0.001801604,0.0004361219,0.004921271,0.3593812,0.0004108336,0.006091474,0.4008163],"study_design_scores_gemma":[0.07402187,0.6938317,0.08319321,0.0001691805,0.001411278,0.004975082,0.0001338518,0.004163535,0.1155301,0.0002094541,0.02231725,0.00004353659],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994123,0.002999097,0.0003872972,0.0001009582,0.00003528593,0.0002701476,0.0002068063,0.00005328159,0.001824035],"genre_scores_gemma":[0.9942279,0.001718602,0.001203942,0.00009404562,0.00004474118,0.0001936968,0.001056915,0.00001252819,0.001447593],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001587103,"threshold_uncertainty_score":0.005309343,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1008776887933599,"score_gpt":0.4609581969056338,"score_spread":0.3600805081122739,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}